test bank for pathophysiology 7th edition by jacquelyn_l._banasik

Test Bank For Pathophysiology 7th Edition by Jacqu
F F F F F F FF



elyn L. Banasik Chapter 1-54-Grades A+-2023- 2024
F F F F F F




Chapter 01: Introduction to Pathophysiology Bana
F F F F F

sik: Pathophysiology, 7th Edition
F F F




MULTIPLEFCHOICE

1. C.Q.FwasFrecentlyFexposedFtoFgroupFAFhemolyticFStreptococcusFandFsubsequentlyFdevelopedFaF
pharyngealFinfection.FHisFclinicFexaminationFrevealsFanForalFtemperatureFofF102.3°F,FskinFrash,F
dysphagia,FandFreddenedFthroatFmucosaFwithFmultipleFpustules.FHeFcomplainsFofFsoreFthroat,Fm
alaise,FandFjointFstiffness.FAFthroatFcultureFisFpositiveFforFStreptococcus,FandFantibioticsFhaveFbe
enFprescribed.FTheFetiologyFofFC.Q.’sFdiseaseFis
a. aFsoreFthroat.
b. streptococcalFinfection.
c. geneticFsusceptibility.
d. pharyngitis.

ANS:F B
EtiologyFrefersFtoFtheFproposedFcauseForFcausesFofFaFparticularFdiseaseFprocess.FAFsoreFthroatFisFt
heFmanifestationFofFtheFdiseaseFprocess.FGeneticFsusceptibilityFrefersFtoFinheritedFtendencyFtoFd
evelopFaFdisease.FPharyngitisFrefersFtoFinflammationFofFtheFthroatFandFisFalsoFaFclinicalFmanifest
ationFofFtheFdiseaseFprocess.

2. AF17-year-oldFcollege-
boundFstudentFreceivesFaFvaccineFagainstFanForganismFthatFcausesFmeningitis.FThisFisFanF
exampleFof
a. primaryFprevention.
b. secondaryFprevention.
c. tertiaryFprevention.
d. diseaseFtreatment.

ANS:F A
PrimaryFpreventionFisFpreventionFofFdiseaseFbyFalteringFsusceptibilityForFreducingFexposureFforF
susceptibleFindividuals,FinFthisFcaseFbyFprovidingFvaccination.FSecondaryFpreventionFisFtheFearl
yFdetection,Fscreening,FandFmanagementFofFtheFdisease.FTertiaryFpreventionFincludesFrehabilitat
iveFandFsupportiveFcareFandFattemptsFtoFalleviateFdisabilityFandFrestoreFeffectiveFfunctioning.FD
iseaseFtreatmentFinvolvesFmanagementFofFtheFdiseaseFonceFitFhasFdeveloped.

3. AnFobeseFbutFotherwiseFhealthyFteenFisFgivenFaFprescriptionFforFaFlow-
calorieFdietFandFexerciseFprogram.FThisFisFanFexampleFof
a. primaryFprevention.
b. secondaryFprevention.
c. tertiaryFprevention.
d. diseaseFtreatment.
ANS:F B
SecondaryFpreventionFisFtheFearlyFdetection,Fscreening,FandFmanagementFofFtheFdiseaseFsuchFasF
prescribingFdietFandFexerciseFforFanFindividualFwhoFhasFalreadyFdevelopedFobesity.FPrimaryFpre
ventionFisFpreventionFofFdiseaseFbyFalteringFsusceptibilityForFreducingFexposureFforFsusceptibleF
individuals.FTertiaryFpreventionFincludesFrehabilitativeFandFsupportiveFcareFandFattemptsFtoFall
eviateFdisabilityFandFrestoreFeffectiveFfunctioning.FDiseaseFtreatmentFinvolvesFmanagementFofFt
heFdiseaseFonceFitFhasFdeveloped.

,4. AFpatientFwithFhighFbloodFpressureFwhoFisFotherwiseFhealthyFisFcounseledFtoFrestrictFsodiumF
intake.FThisFisFanFexampleFof
a. primaryFprevention.
b. secondaryFprevention.
c. tertiaryFprevention.
d. diseaseFtreatment.
ANS:F B
SecondaryFpreventionFisFtheFearlyFdetection,Fscreening,FandFmanagementFofFtheFdisease,FsuchFa
sFbyFprescribingFsodiumFrestrictionFforFhighFbloodFpressure.FPrimaryFpreventionFisFpreventionFo
fFdiseaseFbyFalteringFsusceptibilityForFreducingFexposureFforFsusceptibleFindividuals.FTertiaryFp
reventionFincludesFrehabilitativeFandFsupportiveFcareFandFattemptsFtoFalleviateFdisabilityFandFre
storeFeffectiveFfunctioning.FDiseaseFtreatmentFinvolvesFmanagementFofFtheFdiseaseFonceFitFhasF
developed.

5. AfterFsufferingFaFheartFattack,FaFmiddle-agedFmanFisFcounseledFtoFtakeFaFcholesterol-
loweringFmedication.FThisFisFanFexampleFof
a. primaryFprevention.
b. secondaryFprevention.
c. tertiaryFprevention.
d. diseaseFtreatment.
ANS:F C
TertiaryFpreventionFincludesFrehabilitativeFandFsupportiveFcareFandFattemptsFtoFalleviateFdisabil
ityFandFrestoreFeffectiveFfunctioningFsuchFasFprescribingFaFcholesterol-
loweringFmedicationFfollowingFaFheartFattack.FPrimaryFpreventionFisFpreventionFofFdiseaseFbyFal
teringFsusceptibilityForFreducingFexposureFforFsusceptibleFindividuals.FSecondaryFpreventionFisF
theFearlyFdetection,Fscreening,FandFmanagementFofFtheFdisease.FDiseaseFtreatmentFinvolvesFma
nagementFofFtheFdiseaseFonceFitFhasFdeveloped.

6. AFpatientFhasFbeenFexposedFtoFmeningococcalFmeningitis,FbutFisFnotFyetFdemonstratingFsignsFofF
thisFdisease.FThisFstageFofFillnessFisFcalledFthe stage.
a. prodromal
b. latent
c. sequela
d. convalescence
ANS:F B
IncubationFrefersFtoFtheFintervalFbetweenFexposureFofFaFtissueFtoFanFinjuriousFagentFandFtheFfirstF
appearanceFofFsignsFandFsymptoms.FInFinfectiousFdiseases,FthisFperiodFisFoftenFcalledFtheFincuba
tionF(latent)Fperiod.FProdromalFrefersFtoFtheFappearanceFofFtheFfirstFsignsFandFsymptomsFindicat
ingFtheFonsetFofFaFdisease.FTheseFareFoftenFnonspecific,FsuchFasFheadache,Fmalaise,Fanorexia,Fan
dFnausea,FwhichFareFassociatedFwithFaFnumberFofFdifferentFdiseases.FSequelaFrefersFtoFsubseque
ntFpathologicFconditionFresultingFfromFaFdisease.FConvalescenceFisFtheFstageFofFrecoveryFafterFa
Fdisease,Finjury,ForFsurgicalFoperation.




7. AFdiseaseFthatFisFnativeFtoFaFparticularFregionFisFcalled
a. epidemic.
b. endemic.
c. pandemic.
d. ethnographic.

, ANS:F B
AFdiseaseFthatFisFnativeFtoFaFparticularFregionFisFcalledFendemic.FAnFepidemicFisFaFdiseaseFthatFspre
adsFtoFmanyFindividualsFatFtheFsameFtime.FPandemicsFareFepidemicsFthatFaffectFlargeFgeographicFr
egions,FperhapsFspreadingFworldwide.FEthnographicFdoesFnotFdescribeFaFdiseaseFdistributionFpatte
rn.

8. InFgeneral,FwithFaging,ForganFsizeFandFfunction
a. increase.
b. decrease.
c. remainFtheFsame.
d. areFunknown.

ANS:F B
InFgeneral,FwithFaging,ForganFsizeFandFfunctionFdecrease.

9. TheFstageFduringFwhichFtheFpatientFfunctionsFnormally,FalthoughFtheFdiseaseFprocessesFareFwellF
established,FisFreferredFtoFas
a. latent.
b. subclinical.
c. prodromal.
d. convalescence.
ANS:F B
TheFstageFduringFwhichFtheFpatientFfunctionsFnormally,FalthoughFtheFdiseaseFprocessesFareFwellF
established,FisFcalledFtheFsubclinicalFstage.FTheFintervalFbetweenFexposureFofFaFtissueFtoFanFinju
riousFagentFandFtheFfirstFappearanceFofFsignsFandFsymptomsFmayFbeFcalledFaFlatentFperiodFor,Fin
FtheFcaseFofFinfectiousFdiseases,FanFincubationFperiod.FTheFprodromalFperiod,ForFprodrome,Frefe

rsFtoFtheFappearanceFofFtheFfirstFsignsFandFsymptomsFindicatingFtheFonsetFofFaFdisease.FConvales
cenceFisFtheFstageFofFrecoveryFafterFaFdisease,Finjury,ForFsurgicalFoperation.

MULTIPLEFRESPONSE

1. YourFpatient’sFredFbloodFcellFcountFisFslightlyFelevatedFtoday.FThisFmightFbeFexplainedFbyF
(SelectFallFthatFapply.)
a. genderFdifference.
b. situationalFfactors.
c. normalFvariation.
d. culturalFvariation.
e. illness.
ANS:F A,FB,FC,FE
Gender,FsituationsF(e.g.,Faltitude),FnormalFvariations,FandFillnessFmayFallFdetermineFredFbloodFce
llFcount.FCultureFaffectsFhowFmanifestationsFareFperceivedF(normalFversusFabnormal).

2. SocioeconomicFfactorsFinfluenceFdiseaseFdevelopmentFbecauseFofF(SelectFallFthatFapply.)
a. genetics.
b. environmentalFtoxins.
c. overcrowding.
d. nutrition.
e. hygiene.

, ANS:F B,FC,FD,FE
SocioeconomicFfactorsFinfluenceFdiseaseFdevelopmentFviaFexposureFtoFenvironmentalFtoxinsF(occ
upational)FandFovercrowding,FnutritionF(over-
ForFundernutrition),FandFhygieneF(e.g.,FinFdevelopingFcountries).FGeneticsFisFnotFinfluencedFbyFsoc

ioeconomicFfactors.

3. WhenFdeterminingFadditionalFdataFtoFgatherFbeforeFmakingFaFdiagnosis,FwhatFfactorsFneedFtoF
beFconsidered?F(SelectFallFthatFapply.)
a. Reliability
b. Expense
c. Validity
d. Generalizability
e. Repetition
ANS:F A,FC
TwoFconsiderationsFoneFmustFuseFwhenFchoosingFadditionalFdataFtoFgatherFincludeFtheFreliabilit
yFandFvalidityFofFtheFtestsFbeingFweighed.FReliability,ForFprecision,FisFtheFabilityFofFaFtestFtoFgiv
eFtheFsameFresultFinFrepeatedFmeasurements.FValidity,ForFaccuracy,FisFtheFdegreeFtoFwhichFaFme
asurementFreflectsFtheFtrueFvalueFofFtheFobjectFitFisFintendedFtoFmeasure.FExpense,Fgeneralizabili
ty,FandFrepetitionFareFnotFcharacteristicsFthatFareFtypicallyFconsidered.

4. WhichFofFtheFfollowingFstatementsFareFaccurateFwhenFconsideringFdiagnosticFtestingFforFanF
individualFwithFaFpossibleFmedicalFcondition?F(SelectFallFthatFapply.)
a. TheFmoreFoftenFaFpatientFhasFaFtest,FtheFmoreFaccurateFtheFaverageFresultFis.
b. SensitivityFisFtheFchanceFtheFtestFwillFbeFpositiveFifFtheFhypothesizedFdiseaseFisF
present.
c. TestingFisFgenerallyFnotFaccurateFduringFtheFprodromalFstageFtoFmakeFaFdiagnosis.
d. SpecificityFshowsFthatFaFtestFwillFbeFnegativeFifFtheFpersonFdoesFnotFhaveFtheF
disease.
e. ReliabilityFdemonstratesFaFtestFisFaccurateFunderFaFnumberFofFdifferentFconditions.
ANS:F B,FD
SensitivityFisFtheFprobabilityFthatFtheFtestFwillFbeFpositiveFwhenFappliedFtoFaFpersonFwithFtheFco
ndition.FSpecificityFisFtheFprobabilityFthatFaFtestFwillFbeFnegativeFwhenFappliedFtoFaFpersonFwhoF
doesFnotFhaveFaFgivenFcondition.FTestFresultsFareFusuallyFnotFaggregatedFandFaveraged.FAFdiseas
eFprocessFisFwellFestablishedFduringFtheFprodromalFphaseFofFillness,FsoFsomeFdiagnosticFtestingF
wouldFindicateFitsFpresence.FReliability,ForFprecision,FisFtheFabilityFofFaFtestFtoFgiveFtheFsameFres
ultFinFrepeatedFmeasurements.
Chapter 02: Homeostasis, Allostasis, and Adaptive Responses to Stressors Ba
F F F F F F F F F

nasik: Pathophysiology, 7th Edition
F F F




MULTIPLEFCHOICE

1. IndicatorsFthatFanFindividualFisFexperiencingFhighFstressFincludeFallFtheFfollowingFexcept
a. tachycardia.
b. diaphoresis.
c. increasedFperipheralFresistance.
d. pupilFconstriction.

ANS:F D